- Home
- / Spark Therapeutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Spark Therapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$113.6
2019-12-17
Market Capitalization
$4.4 B
2019-12-17
Revenue
$64.7 M
FY, 2018
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 |
|---|---|---|---|---|---|
| Revenue | 633.9K | 22.1M | 20.2M | 12.1M | 64.7M |
| Revenue growth, % | 3380.4% | -8.5% | |||
| General and administrative expense | 7.9M | 23.4M | 48.1M | 111.1M | 124.9M |
| Operating expense total | 24.2M | 69.4M | 134.4M | 246.3M | 250.1M |
| EBIT | (24.3M) | (47.3M) | (125.4M) | (258.5M) | (193.6M) |
| EBIT margin, % | -3838.0% | -214.5% | -621.3% | -2142.6% | -299.2% |
| Interest income | 192.0K | ||||
| Interest expense | 1.7M | 4.1M | 10.0M | ||
| Pre tax profit | (239.3M) | (79.0M) | |||
| Income tax expense | (963.0K) | 99.0K | |||
| Net Income | (24.3M) | (47.1M) | (123.7M) | (253.5M) | (78.8M) |